vs

Side-by-side financial comparison of First Foundation Inc. (FFWM) and Outset Medical, Inc. (OM). Click either name above to swap in a different company.

First Foundation Inc. is the larger business by last-quarter revenue ($48.4M vs $28.9M, roughly 1.7× Outset Medical, Inc.). Outset Medical, Inc. runs the higher net margin — -67.5% vs -97.9%, a 30.4% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs -2.0%). Outset Medical, Inc. produced more free cash flow last quarter ($-9.7M vs $-35.2M). Over the past eight quarters, Outset Medical, Inc.'s revenue compounded faster (1.2% CAGR vs -2.7%).

John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

FFWM vs OM — Head-to-Head

Bigger by revenue
FFWM
FFWM
1.7× larger
FFWM
$48.4M
$28.9M
OM
Growing faster (revenue YoY)
FFWM
FFWM
+423.7% gap
FFWM
421.7%
-2.0%
OM
Higher net margin
OM
OM
30.4% more per $
OM
-67.5%
-97.9%
FFWM
More free cash flow
OM
OM
$25.5M more FCF
OM
$-9.7M
$-35.2M
FFWM
Faster 2-yr revenue CAGR
OM
OM
Annualised
OM
1.2%
-2.7%
FFWM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FFWM
FFWM
OM
OM
Revenue
$48.4M
$28.9M
Net Profit
$-8.0M
$-19.5M
Gross Margin
42.4%
Operating Margin
-97.5%
-61.1%
Net Margin
-97.9%
-67.5%
Revenue YoY
421.7%
-2.0%
Net Profit YoY
43.0%
24.0%
EPS (diluted)
$-0.09
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FFWM
FFWM
OM
OM
Q4 25
$48.4M
$28.9M
Q3 25
$63.6M
$29.4M
Q2 25
$51.4M
$31.4M
Q1 25
$71.4M
$29.8M
Q4 24
$9.3M
$29.5M
Q3 24
$9.2M
$28.7M
Q2 24
$57.5M
$27.4M
Q1 24
$51.1M
$28.2M
Net Profit
FFWM
FFWM
OM
OM
Q4 25
$-8.0M
$-19.5M
Q3 25
$-146.3M
$-17.8M
Q2 25
$-7.7M
$-18.5M
Q1 25
$6.9M
$-25.8M
Q4 24
$-14.1M
$-25.6M
Q3 24
$-82.2M
$-27.9M
Q2 24
$3.1M
$-34.5M
Q1 24
$793.0K
$-39.9M
Gross Margin
FFWM
FFWM
OM
OM
Q4 25
42.4%
Q3 25
39.4%
Q2 25
37.8%
Q1 25
37.2%
Q4 24
36.5%
Q3 24
34.3%
Q2 24
35.7%
Q1 24
29.2%
Operating Margin
FFWM
FFWM
OM
OM
Q4 25
-97.5%
-61.1%
Q3 25
-92.7%
-53.7%
Q2 25
-21.1%
-53.7%
Q1 25
8.8%
-55.1%
Q4 24
-247.7%
-74.2%
Q3 24
-1276.7%
-83.2%
Q2 24
4.6%
-112.3%
Q1 24
-0.2%
-131.0%
Net Margin
FFWM
FFWM
OM
OM
Q4 25
-97.9%
-67.5%
Q3 25
-230.1%
-60.6%
Q2 25
-15.0%
-59.0%
Q1 25
9.7%
-86.7%
Q4 24
-152.2%
-87.0%
Q3 24
-896.9%
-97.5%
Q2 24
5.4%
-125.8%
Q1 24
1.6%
-141.8%
EPS (diluted)
FFWM
FFWM
OM
OM
Q4 25
$-0.09
$0.33
Q3 25
$-1.78
$-1.00
Q2 25
$-0.09
$-1.04
Q1 25
$0.08
$-3.66
Q4 24
$-0.24
$-7.21
Q3 24
$-1.23
$-8.02
Q2 24
$0.05
$-9.96
Q1 24
$0.01
$-11.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FFWM
FFWM
OM
OM
Cash + ST InvestmentsLiquidity on hand
$1.6B
$168.9M
Total DebtLower is stronger
$96.2M
Stockholders' EquityBook value
$912.6M
$127.0M
Total Assets
$11.9B
$264.5M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FFWM
FFWM
OM
OM
Q4 25
$1.6B
$168.9M
Q3 25
$1.7B
$178.6M
Q2 25
$1.1B
$184.1M
Q1 25
$1.0B
$189.0M
Q4 24
$1.0B
$158.7M
Q3 24
$1.1B
$175.6M
Q2 24
$1.4B
$194.8M
Q1 24
$1.6B
$226.9M
Total Debt
FFWM
FFWM
OM
OM
Q4 25
$96.2M
Q3 25
Q2 25
Q1 25
Q4 24
$197.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FFWM
FFWM
OM
OM
Q4 25
$912.6M
$127.0M
Q3 25
$917.9M
$142.4M
Q2 25
$1.1B
$154.8M
Q1 25
$1.1B
$169.9M
Q4 24
$1.1B
$26.8M
Q3 24
$1.1B
$47.8M
Q2 24
$933.2M
$68.6M
Q1 24
$928.7M
$93.2M
Total Assets
FFWM
FFWM
OM
OM
Q4 25
$11.9B
$264.5M
Q3 25
$11.9B
$277.3M
Q2 25
$11.6B
$288.8M
Q1 25
$12.6B
$301.2M
Q4 24
$12.6B
$275.8M
Q3 24
$13.4B
$292.9M
Q2 24
$13.7B
$314.5M
Q1 24
$13.6B
$346.2M
Debt / Equity
FFWM
FFWM
OM
OM
Q4 25
0.76×
Q3 25
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FFWM
FFWM
OM
OM
Operating Cash FlowLast quarter
$-31.9M
$-9.5M
Free Cash FlowOCF − Capex
$-35.2M
$-9.7M
FCF MarginFCF / Revenue
-72.8%
-33.7%
Capex IntensityCapex / Revenue
6.9%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-45.9M
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FFWM
FFWM
OM
OM
Q4 25
$-31.9M
$-9.5M
Q3 25
$9.2M
$-6.3M
Q2 25
$-16.3M
$-4.8M
Q1 25
$-552.0K
$-25.7M
Q4 24
$-8.7M
$-16.5M
Q3 24
$14.2M
$-20.6M
Q2 24
$-9.1M
$-33.3M
Q1 24
$7.2M
$-45.9M
Free Cash Flow
FFWM
FFWM
OM
OM
Q4 25
$-35.2M
$-9.7M
Q3 25
$8.6M
$-6.5M
Q2 25
$-16.7M
$-5.1M
Q1 25
$-2.5M
$-25.8M
Q4 24
$-11.4M
$-16.5M
Q3 24
$13.4M
$-21.0M
Q2 24
$-9.4M
$-33.5M
Q1 24
$5.9M
$-46.3M
FCF Margin
FFWM
FFWM
OM
OM
Q4 25
-72.8%
-33.7%
Q3 25
13.5%
-22.0%
Q2 25
-32.4%
-16.3%
Q1 25
-3.5%
-86.7%
Q4 24
-123.5%
-56.1%
Q3 24
146.2%
-73.1%
Q2 24
-16.3%
-122.2%
Q1 24
11.6%
-164.3%
Capex Intensity
FFWM
FFWM
OM
OM
Q4 25
6.9%
0.8%
Q3 25
1.0%
0.5%
Q2 25
0.8%
0.9%
Q1 25
2.8%
0.4%
Q4 24
29.4%
0.1%
Q3 24
9.0%
1.4%
Q2 24
0.4%
0.4%
Q1 24
2.5%
1.3%
Cash Conversion
FFWM
FFWM
OM
OM
Q4 25
Q3 25
Q2 25
Q1 25
-0.08×
Q4 24
Q3 24
Q2 24
-2.96×
Q1 24
9.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FFWM
FFWM

Segment breakdown not available.

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

Related Comparisons